CV Sciences (CVSI) Cash from Investing Activities (2013 - 2026)
CV Sciences (CVSI) posted Cash from Investing Activities of -$3000.0 for Q1 2026, up 66.67% sequentially from -$9000.0 in Q4 2025, and up 92.5% YoY from -$1558.4 in Q1 2025.
CV Sciences (CVSI) Cash from Investing Activities (2013 - 2026) Analysis & Trends
CV Sciences has reported Cash from Investing Activities for 13 years, with the latest figure at -$3000.0 in Q1 2026.
- Quarterly Cash from Investing Activities rose 92.5% year-over-year to -$3000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$72000.0 (down 5.88% YoY) and the FY2025 annual result came in at -$109000.0, down 289.29% from the prior year.
- Cash from Investing Activities rose to -$3000.0 in Q1 2026 per CVSI's latest filing, from -$9000.0 in the prior quarter.
- Over five years, Cash from Investing Activities peaked at $34000.0 in Q3 2024 and troughed at -$156000.0 in Q4 2023.
- A 4-year average of -$32888.9 and a median of -$22000.0 in 2024 frame the typical range for Cash from Investing Activities.
- The sharpest annual moves came in 2025 and 2026: Cash from Investing Activities plunged 132.35% in 2025, then soared 92.5% in 2026.
- Over 4 years, Cash from Investing Activities stood at -$156000.0 in 2023, then jumped by 85.9% to -$22000.0 in 2024, then surged by 59.09% to -$9000.0 in 2025, then soared by 66.67% to -$3000.0 in 2026.
- According to Business Quant data, Cash from Investing Activities over the past three periods registered -$3000.0, -$9000.0, and -$11000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.96 Bn | 43.00 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.23 Bn | 39.58 Bn | 2.15 Bn | -491.00 Mn |
| 3 | Zoetis | 31.76 Bn | 30.08 Bn | 1.05 Bn | -300.00 Mn |
| 4 | Takeda Pharmaceutical | 28.68 Bn | 22.88 Bn | 5.10 Bn | -550.24 Mn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 87.50 Mn |
| 6 | Viatris | 18.69 Bn | 17.81 Bn | 1.46 Bn | -51.60 Mn |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | -135.40 Mn |
| 8 | Elanco Animal Health | 11.78 Bn | 11.25 Bn | 798.00 Mn | -110.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | - |
| 10 | CV Sciences | 4.10 Mn | 3.84 Mn | 1.45 Mn | -7,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -7,000.00 |
| Jun 30, 2026 | -7,000.00 |
| Mar 31, 2026 | -3,000.00 |
| Mar 31, 2026 | -3,000.00 |
| Dec 31, 2025 | -9,000.00 |
| Dec 31, 2025 | -9,000.00 |
| Sep 30, 2025 | -11,000.00 |
| Sep 30, 2025 | -11,000.00 |
| Jun 30, 2025 | -49,000.00 |
| Jun 30, 2025 | -49,000.00 |
| Mar 31, 2025 | -40,000.00 |
| Mar 31, 2025 | -40,000.00 |
| Dec 31, 2024 | -22,000.00 |
| Dec 31, 2024 | -22,000.00 |
| Sep 30, 2024 | 34,000.00 |
| Sep 30, 2024 | 34,000.00 |
| Jun 30, 2024 | -40,000.00 |
| Jun 30, 2024 | -40,000.00 |
| Dec 31, 2023 | -156,000.00 |
| Dec 31, 2023 | -156,000.00 |